global digital therapeutics market is projected to reach USD 13.1 billion by 2026, at a CAGR of 31.4% during the forecast period. The growth of this market is mainly driven by growing interest in preventive medicine, a significant increase in venture capital investments and the benefits of digital therapy.

Get Sample PDF: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724

Key Market Players of Digital Therapeutics (DTx) Market:

Omada Health (US), WellDoc (US), Pear Therapeutics (US), Better Therapeutics (US), Happify (US), Proteus Digital Health (US), Propeller Health (US), Noom (US), Livongo Health (US), Akili Interactive Labs (US), Kaia Health (Germany)

Covid-19 Impact on the Digital Therapeutics Market

The impact of the coronavirus pandemic and the subsequent establishment of nationwide lockdowns is visible in various industries. The overall growth of various sectors has been heavily impacted, especially in countries with a high incidence rate of COVID-19, such as India, China, Brazil, the US, and several European countries (including Russia, Italy, and Spain). While industries such as oil and petroleum, aeronautics, and mining are experiencing a steep fall in revenues, the healthcare, biotechnology, and pharmaceutical industries are optimizing this situation to serve a maximum number of patients and healthcare professionals.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724

Opportunities: Emerging markets

Emerging economies such as India, China, and the Middle East present growth opportunities for digital therapeutics. In most geographies, the market is still in its infancy due to a lack of awareness, the minimum availability of these solutions, lack of IT infrastructure, and financial and social constraints. On the other hand, most emerging economies show high rates of chronic disease incidence. According to WHO estimates, chronic diseases will be responsible for 70% of the total deaths in developing countries. On the global level, by 2025, ~60% of the burden of chronic conditions will be in developing countries.

These countries have also registered widespread adoption of smartphones and related technologies due to their growing affordability. Globally, China and India are the top two countries in terms of smartphone ownership. Furthermore, the increasing access to smart devices and the Internet has encouraged the development of health apps. In addition, government bodies in these regions are taking initiatives to improve HCIT infrastructure.

Recent Developments:

  • In April 2021, Welldoc(US) partnered with Dexacom (US). This partnership helped provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for improved health.
  • In March 2021, Pear Therapeutics (US) partnered with Sprectrum Health Systems (US). Tufts Health Plan and Spectrum Health Systems announced a collaboration with Pear Therapeutics to test FDA-approved digital therapeutics to help people with substance use disorders and improve their recovery journeys by delivering solutions for improved treatment access and care innovation journeys by delivering solutions for improved treatment access and care innovation

Speak to our analyst for a discussion on the above findings: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724